Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A TEICHER

Showing results (141-150 of 372) with videos related to

Pageof 38
Sort By:
Cancer Research|June 1, 1990
Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcomaB A Teicher, S A Holden, A al-Achi, et al.
Journal of the National Cancer Institute|June 21, 1989
Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiationB A Teicher, T S Herman, S A Holden, et al.
Cancer Research|January 15, 1991
A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicityJ P Eder, C A Wheeler, B A Teicher, et al.
In Vivo (Athens, Greece)|March 24, 1998
Prostate carcinoma response to cytotoxic therapy: in vivo resistanceB A Teicher, Y Kakeji, G Ara, et al.
Radiation Research|August 1, 1997
Apoptosis and clonogenic cell death in PC3 human prostate cancer cells after treatment with gamma radiation and suraminS T Palayoor, E A Bump, B A Teicher, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activityB A Teicher, S D Bernal, S A Holden, et al.
Radiation Research|September 1, 1984
Toxic variability and radiation sensitization by Pt(II) analogs in Salmonella typhimurium cellsR C Richmond, A R Khokhar, B A Teicher, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2001
Cryptophycin-induced hyperphosphorylation of Bcl-2, cell cycle arrest and growth inhibition in human H460 NSCLC cellsK Lu, J Dempsey, R M Schultz, et al.
Radiation Oncology Investigations|May 8, 1998
Optimal scheduling of interleukin-12 and fractionated radiation therapy in the murine Lewis lung carcinomaB A Teicher, G Ara, D Buxton, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 1, 1991
Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiationB A Teicher, M R Pfeffer, E Alvarez Sotomayor, et al.
Pageof 38

Showing results (141-150 of 372) with videos related to

Sort By:
Pageof 38
Cancer Research|June 1, 1990
Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcomaB A Teicher, S A Holden, A al-Achi, et al.
Journal of the National Cancer Institute|June 21, 1989
Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiationB A Teicher, T S Herman, S A Holden, et al.
Cancer Research|January 15, 1991
A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicityJ P Eder, C A Wheeler, B A Teicher, et al.
In Vivo (Athens, Greece)|March 24, 1998
Prostate carcinoma response to cytotoxic therapy: in vivo resistanceB A Teicher, Y Kakeji, G Ara, et al.
Radiation Research|August 1, 1997
Apoptosis and clonogenic cell death in PC3 human prostate cancer cells after treatment with gamma radiation and suraminS T Palayoor, E A Bump, B A Teicher, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activityB A Teicher, S D Bernal, S A Holden, et al.
Radiation Research|September 1, 1984
Toxic variability and radiation sensitization by Pt(II) analogs in Salmonella typhimurium cellsR C Richmond, A R Khokhar, B A Teicher, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2001
Cryptophycin-induced hyperphosphorylation of Bcl-2, cell cycle arrest and growth inhibition in human H460 NSCLC cellsK Lu, J Dempsey, R M Schultz, et al.
Radiation Oncology Investigations|May 8, 1998
Optimal scheduling of interleukin-12 and fractionated radiation therapy in the murine Lewis lung carcinomaB A Teicher, G Ara, D Buxton, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 1, 1991
Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiationB A Teicher, M R Pfeffer, E Alvarez Sotomayor, et al.
Pageof 38